Tereassa Archibeque Selected Research

rhuMAb-E25

1/2010

Reduced FcepsilonRI-mediated release of asthma-promoting cytokines and chemokines from human basophils during omalizumab therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tereassa Archibeque Research Topics

Disease

3	Asthma (Bronchial Asthma) 01/2010 - 04/2007
1	Inflammation (Inflammations) 01/2010

Drug/Important Bio-Agent (IBA)

1	Omalizumab (Xolair)FDA Link 01/2010
1	rhuMAb-E25IBA 01/2010
1	CytokinesIBA 01/2010
1	ChemokinesIBA 01/2010
1	Immunoglobulin E (IgE)IBA 01/2010
1	AllergensIBA 02/2009
1	AdiponectinIBA 02/2009
1	Histamine (Histamine Dihydrochloride)FDA Link 04/2007

Therapy/Procedure

1	Therapeutics 01/2010